Search by property

This page provides a simple browsing interface for finding entities described by a property and a named value. Other available search interfaces include the page property search, and the ask query builder.

List of results

• Hodgson et al. (2012): Reflexology versus Swedish Massage to Reduce Physiologic Stress and Pain and Improve Mood in Nursing Home Residents with Cancer: A Pilot Trial.  + (T0: Early morning, 7-7:30 am; T1: mid morning, 11-11:30 am; T2: Early afternoon, 1-1:30 pm; T3: late afternoon, 4-4:30 pm)
• Barton et al. (1998): Prospective evaluation of vitamin E for hot flashes in breast cancer survivors  + (T0: Week -1 Vitamin E (measured for 1 week) T1: after 4 weeks T2: after 8 weeks)
• Lin et al. (2008): Effects of zinc supplementation on clinical outcomes in patients receiving radiotherapy for head and neck cancers: a double-blinded randomized study  + (T0: after radiotherapy Follow-Up: every 3 months after therapy)
• Urashima et al. (2019): Effect of Vitamin D Supplementation on Relapse-Free Survival Among Patients With Digestive Tract Cancers The AMATERASU Randomized Clinical Trial  + (T0: baseline Every month for the first 6 … T0: baseline</br></br>Every month for the first 6 months</br></br>Every 2 months for the second 6 months</br></br>Every 3 months thereafter until 5 years</br></br>After 5 years, follow-up continued to occur every 3 to 6 months depending on a patient’s condition as judged by the surgeon in chargendition as judged by the surgeon in charge)
• Strasser et al. (2006): Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled (…)  + (T0: baseline T1: after 2 weeks T2: after 4 weeks T3: after 6 weeks)
• Shokri et al. (2017): Comparison of the Complications of Platinum-Based Adjuvant Chemotherapy With and Without Ginger in a Pilot Study on Ovarian Cancer Patients  + (T0: baseline T1: after 3 months T2: after 6 months T3: after 9 months T4: after 12 months)
• Lichtmann et al. (2018): Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain  + (T0: baseline T1: after 3 weeks (21 days) T2: after 5 weeks (35 days) T3: after 7 weeks follow-up (up to day 43))
• Fallon et al. (2017) I: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies  + (T0: baseline T1: after 3 weeks (day 22) T2: after 5 weeks (day 36) Follow-up: after 7 weeks (up to day 43))
• Fallon et al. (2017) II: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies  + (T0: baseline T1: after 3 weeks (day 22) T2: after 5 weeks (day 36) Follow-up: after 7 weeks (up to day 43))
• Lissoni et al. (1998): Biotherapy with the Pineal Immunomodulating Hormone Melatonin versus Melatonin plus Aloe vera in Untreatable Advanced Solid Neoplasms  + (T0: baseline T1: 2-month-intervals until progression of diasease Follow-up: after 1 year)
• Hershman et al. (2013): Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy  + (T0: baseline T1: after 12 weeks T2: after 24 weeks T3: after 36 weeks T4: after 52 weeks T5: after 104 weeks)
• Freedland et al. (2020): A Randomized Controlled Trial of a 6-month low carbohydrate intervention on disease progression in men with recurrent prostate cancer: Carbohydrate and Prostate Study 2 (CAPS2)  + (T0: baseline T1: after 3 months T2: after 6 months)
• Jatoi et al. (2002): Dronabinol Versus Megestrol Acetate Versus Combination Therapy for Cancer-Associated Anorexia: A North Central Cancer Treatment Group Study  + (T0: baseline T1: end of study (no clear end of study defined))
• Niravath et al. (2019): Randomized controlled trial of high‐dose versus standard‐dose vitamin D3 for prevention of aromatase inhibitor‐induced arthralgia  + (T0: baseline T1: week 12 T2: week 52)
• Keshavarzi et al. (2019): The effect of vitamin D and E vaginal suppositories on tamoxifen-induced vaginal atrophy in women with breast cancer  + (T0: baseline T1: week 2 T2: week 4 T3: week 8)
• Grimison et al. (2020): Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial  + (T0: baseline T1: one day before chemotherapy T2: day 8 of each cycle T3: between 30-42 days after end of intervention)
• Hoopfer et al. (2015): Three-arm randomized phase III trial: Quality aloe and placebo cream versus powder as skin treatment during breast cancer radiation therapy  + (T0: baseline T1: weekly until end of radiation T2: week 1, 2, and 4 after end of radiation)
• Johnson et al. (2010): Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain  + (T0: baseline (2 days) T1: after 7-10 days T2: after 14-20 days)
• Raoufinejad et al. (2019): Oral calcitriol in hematopoietic recovery and survival after autologous stem cell transplantation: a randomized clinical trial  + (T0: baseline (day 0: allocation) T1: after 15 days T2: after 30 days T3: after 180 days T4: after 365 days Follow-up: 2 years)
• Heggie et al. (2002): A phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue  + (T0: baseline = day 1 of radiation treatment T1: weekly throughout radiation treatment Follow-up: 2 weeks after treatment)
• Antunac et al. (2018): Vitamin D Supplementation and Survival in Metastatic Colorectal Cancer  + (T0: baseline before first cycle of chemotherapy afterwards: observation over 2 years or until death)
• Côté et al. (2016): Improving Quality of Life With Nabilone During Radiotherapy Treatments for Head and Neck Cancers: A Randomized Double-Blind Placebo-Controlled Trial  + (T0: baseline before radiotherapy T1: first week T2: second week until T3: 7^th week Follow-up: between 9^th - 11^th week)
• Ribeiro et al. (2017): Effects of zinc supplementation on fatigue and quality of life in patients with colorectal cancer  + (T0: baseline before the beginning of supplementation T1-T4: before each of the four cycles of chemotherapy)
• Ng et al. (2019): Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial  + (T0: basline T1: after cycle 4 of chemotherapy (8 weeks) T2: after cycle 8 of chemotherapy (16 weeks) Follow-Up (End of study))
• Brown et al. (2019): Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Body Composition among Patients with Advanced or Metastatic Colorectal Cancer: A Randomized Trial  + (T0: basline T1: after cycle 4 of chemotherapy (8 weeks) T2: after cycle 8 of chemotherapy (16 weeks) Follow-Up)

• Inglis et al. (2020): Effects of High-Dose Vitamin D Supplementation on Phase Angle and Physical Function in Patients with Prostate Cancer on ADT  + (T0: basline T1: week 12 T2: week 24)

• Cruciani et al. (2009): L-Carnitine Supplementation in Patients with Advanced Cancer and Carnitine Deficiency: A Double-Blind, Placebo-Controlled Study  + (T0: before intervention (baseline) T1: 2 weeks (end of phase 1) T2: 1 week after the start of the intervention T3: 4 weeks (end of phase 2))
• Hajimohammadebrahim-Ketabforoush et al. (2019): Effect of Vitamin D Supplementation on Postcraniotomy Pain After Brain Tumor Surgery: A Randomized Clinical Trial  + (T0: before operation T1-T3: on day 1-3 after operation T4: on day 5 after operation)
• Sangthawan et al. (2013): A randomized double-blind, placebo-controlled trial of zinc sulfate supplementation for alleviation of radiation-induced oral mucositis and pharyngitis in head and neck cancer patients  + (T0: before radiation weekly during radiation Follow-Up: 1 month after completion of radiation)
• Lin et al. (2010): Discrepancy of the effects of zinc supplementation on the prevention of radiotherapy-induced mucositis between patients with nasopharyngeal carcinoma and those with oral cancers: subgroup analysis of a double-blind, randomized study  + (T0: before radiotherapy 1st Follow-Up at 3 months after radiotherapy 2nd Follow-Up at 12 months after radiotherapy)
• Gorgu et al. (2013): The effect of zinc sulphate in the prevention of radiation induced oral mucositis in patents with head and neck cancer  + (T0: before radiotherapy Once a week during radiotherapy After radiotherapy)
• Ertekin et al. (2004): Zinc sulfate in the prevention of radiation-induced oropharyngeal mucositis: a prospective, placebo-controlled, randomized study  + (T0: before radiotherapy Once a week during treatment After treatment 6 weeks after treatment)
• Lin et al. (2006): Zinc supplementation to improve mucositis and dermatitis in patients after radiotherapy for head-and-neck cancers: a double-blind, randomized study  + (T0: before radiotherapy T1: after radiotherapy 1st Follow-Up at 3 months after radiotherapy 2nd Follow-Up at 12 months after radiotherapy)
• Bairati et al. (2005): A Randomized Trial of Antioxidant Vitamins to Prevent Second Primary Cancers in Head and Neck Cancer Patients  + (T0: before radiotherapy T1: during radiotherapy T2: immediately post-radiotherapy T3: 1 month post-radiotherapy from T4: every 6 months for 3 years, then once a year until 30.06.2003)
• Bairati et al. (2005): Randomized Trial of Antioxidant Vitamins to Prevent Acute Adverse Effects of Radiation Therapy in Head and Neck Cancer Patients  + (T0: before radiotherapy T1: during radiotherapy T2: immediately post-radiotherapy T3: 1 month post-radiotherapy from T4: every 6 months for 3 years, then once a year until 30.06.2003)
• Bairati et al. (2006): Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients  + (T0: before radiotherapy T1: during radiotherapy T2: immediately post-radiotherapy T3: 1 month post-radiotherapy from T4: every 6 months for 3 years, then once a year until 30.06.2003)
• Chung et al. (2016): Randomized Trial of Vitamin C/E Complex for Prevention of Radiation- Induced Xerostomia in Patients with Head and Neck Cancer  + (T0: before radiotherapy, T1: 1 month post-radiotherapy, T2: 6 months post-radiotherapy)
• Delanian et al. (2003): Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis  + (T0: before randomization T1: after 3 months T2: after 6 months)
• Thamlikitkul et al. (2017): Efficacy of ginger for prophylaxis of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adriamycin–cyclophosphamide regimen: a randomized, double-blind, placebo-controlled, crossover study  + (T0: during first chemotherapy cycle T1: 0-24h (within 24h after chemotherapy) T2: >24h (after chemotherapy))
• Iovino et al. (2018): High-dose zinc oral supplementation after stem cell transplantation causes an increase of TRECs and CD4+ naive lymphocytes and prevents TTV reactivation  + (T0: first day of stem cell collection T1: the day before the starting of the conditioning treatment T2: day +30 after transplant T3: day +100 after transplant)
• Braga et al. (2015): Effect of Zinc Supplementation on Serological Response to Vaccination Against Streptococcus Pneumoniae in Patients Undergoing Chemotherapy for Colorectal Cancer  + (T0: perioperative (prior to vaccination) T1: before the chemotherapy (4th wk of study) T2: after 3 cycles of chemotherapy (16th wk of study))
• Koyama et al. (2017): Intravenous Carnitine Administration in Addition to Parenteral Nutrition With Lipid Emulsion May Decrease the Inflammatory Reaction in Postoperative Surgical Patients  + (T0: preoperative phase T1: 1 day after surgery T2-T7: Day 2-7 after surgery Blood samples at T0, T1, T3 and T4; carnitine concentration at T0, T1, T3, T7; C-reactive protein (CRP) at T3 and T7, urine samples at T3 and T7)
• Ota et al. (2014): The effect of pyridoxine for prevention of hand-foot-syndrome in colorectal cancer patients with adjuvant chemotherapy using capecitabine: A randomized study  + (T0: pretreatment T1: before each chemotherapy cycle T2: follow-up after chemotherapy)
• Pace et al. (2003): Neuroprotective Effect of Vitamin E Supplementation in Patient Treated With Cisplatin Chemotherapy  + (T0: prior to chemotherapy T1: after 3. chemotherapy-cycle T2: 1 month after chemotherapy)
• Lyckholm et al. (2012): A randomized, placebo controlled trial of oral zinc for chemotherapy-related taste and smell disorders  + (T0: prior to intervention T1-T3: at 1, 2, and 3 months after initiating zinc versus placebo)
• Ripamonti et al. (1998): A randomized, controlled clinical trial to evaluate the effects of zinc sulfate on cancer patients with taste alterations caused by head and neck irradiation  + (T0: prior to radiotherapy, weekly intervals during radiotherapy Follow-Up: 1 month after radiotherapy)
• Cavallini et al. (2005): Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy  + (T0: prior to therapy T1: 4 month of therapy)
• Hejazi et al. (2013): A pilot clinical trial of radioprotective effects of curcumin supplementation in patients with prostate cancer  + (T0: week -1 radiotherapy T1: 3 months after radiotherapy (20 weeks after T0))
• Hejazi et al. (2016): Effect of Curcumin Supplementation During Radiotherapy on Oxidative Status of Patients with Prostate Cancer: A Double Blinded, Randomized, Placebo-Controlled Study  + (T0: week -1 radiotherapy T1: 3 months after radiotherapy (20 weeks after T0))
• Scher et al. (2011): Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer  + (T0: within 14 days of random assignment 72 hours preceding each day 2 Follow-Up: after 48 weeks (only for survival))
• Braik et al. (2014): Randomized trial of vitamin B6 for preventing hand-foot syndrome from capecitabine chemotherapy  + (T1-T4: week 3 of each chemotherapy cycle)